Psychopharmacology and Psychiatry Updates cover image

Lithium vs. Quetiapine: Augmenting Treatment-Resistant Depression

Psychopharmacology and Psychiatry Updates

00:00

Risk-Benefit Considerations in Augmentation

Paul Zarkowski argues that both medications have concerning profiles and should be justified especially in bipolar depression.

Play episode from 08:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app